Oral suspension formulation

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S400000, C514S937000

Reexamination Certificate

active

10115792

ABSTRACT:
An aqueous pharmaceutical suspension for oral administration of a drug, which suspension maintains its content uniformity for prolonged period.

REFERENCES:
patent: 4607050 (1986-08-01), Kieran et al.
patent: 4975465 (1990-12-01), Motola et al.
patent: 5112604 (1992-05-01), Beaurline et al.
patent: 5272137 (1993-12-01), Blasé et al.
patent: 5374659 (1994-12-01), Gowan, Jr.
patent: 5409907 (1995-04-01), Blase et al.
patent: 5621005 (1997-04-01), Gowan, Jr.
patent: 5658919 (1997-08-01), Ratnaraj et al.
patent: 5712310 (1998-01-01), Koch
patent: 5759579 (1998-06-01), Singh et al.
patent: 6231890 (2001-05-01), Naito et al.
patent: 2002/0039594 (2002-04-01), Unger
patent: 2003/0072800 (2003-04-01), Singh et al.
Nakhare et al. (“Prolonged release of rifampicin from multiple W/O/W emulsion,” in J. Microencapsulation, 1995, vol. 12, No. 4, 409-415).
Pages 340 and 831 of The Condensed Chemical Dictionary, Ninth edition, 1977, edited by Hawley, Gessner G.
Page 298 of Remington's Pharmaceutical Sciences, eighteenth edition, 1990, edited by Gennaro, Alfonso R.
Ofner, Schnaare and Schwartz, “Oral Aqueous Suspensions.” Pharmaceutical Dosage Form: Disperse Systems, vol. 2, edited by Lieberman, Ricger, and Banker, First Edition, pp. 234-236.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oral suspension formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral suspension formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral suspension formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3869782

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.